Had a fantastic time presenting my research at MathOnco25. Looking forward to IMO workshop! @mathonco.bsky.social

Last speaker at #MathOnco25 is our own @mathonco.bsky.social Jeffrey West that provides a study of the #mathonco literature to produce this definition of MathOnco: the use of interpretable models to understand and improve cancer therapy

Great last didactic at #MathOnco25 by @andriy-marusyk.bsky.social describing the complex landscape of evolutionary and ecological mechanisms aiding cancers become treatment-resistant. Andriy and I both share the idea of maps as an example of what models can be

4th (and last) day of #MathOnco25. Excellent work @sandyanderson.bsky.social and @gliomath.bsky.social. Looking forward the next one, hopefully in 2026

Last keynote at #MathOnco25 by Sarah Bruningk talking about #AI in #Medicine. While generally optimistic about AI in medicine she is aware of the challenge that AI works best when there is a lot of data and that is almost never the case in clinical oncology

In her #MathOnco25 plenary, Sarah Brüningk motivates mechanistic learning in mathematical oncology, drawing on her recent review paper: www.frontiersin.org/journals/imm...

Bob Gatenby finishes his phenomenal #MathOnco25 talk with this stunning figure and conclusion: "Cycles within cycles may allow metastatic prostate cancer to be converted to a chronic disease". The results are from a new paper: onlinelibrary.wiley.com/doi/10.1002/...

Joel Brown at #MathOnco25 draws parallels between the evolution and ecology of cancer and of dogs, elephant shrews and (of course) squirrels. Cancer redefined as "a disease of uncontrolled proliferation by transformed cells subject to evolution by natural selection". aacrjournals.org/mcr/article/...

Now @kitcgallagher.bsky.social at #MathOnco25 presents his recent research on predicting treatment outcomes to identify which patients will benefit the most from adaptive therapy. Preprints and papers at scholar.google.com/citations?us...

Franco Pradelli presents one of the most beautiful slides so far at #MathOnco25, on the topic of exploiting the cost of addiction in anaplastic large cell lymphoma

Fantastic to have adaptive therapy pioneer Jingsong Zhang here at #MathOnco25 talking about a third-generation adaptive therapy trial for metastatic prostate cancer underway at the Moffitt Cancer Center, informed by Jill Gallagher's mathematical modelling. Preprint: www.medrxiv.org/content/10.1...

Thursday keynote at #MathOnco25 with @robjohnnoble.bsky.social showing a wealth of #MathOnco models of cancer evolution and evolutionary-enlightened therapies. Notice the bingo card: he showed enough different math models to fill up the card!

Really nice #MathOnco25 talk by Einar Bjarki Gunnarsson on optimal dosing of anti-cancer treatment under drug-induced plasticity, showing "that the optimal dosing strategy steers the tumor to a fixed equilibrium composition between sensitive and tolerant cells" www.nature.com/articles/s41...

Now at #MathOnco25, co-organiser @gliomath.bsky.social presents recent work showing that the predictions of an AI method massively improved when coupled with a mechnaistic mathematical model www.nature.com/articles/s41...

From Tampa to the gorgeous St. Pete for #MathOnco25. Science and views for the next few days! 😍

Great talk by collaborator Joon Hyun Song from @ceel-damaghilab.bsky.social working on a simple model of the storage effect to explain the role of temporal fluctuations in intra tumor heterogeneity #MathOnco25

At #MathOnco25, @rrockne.bsky.social explains why he so loves SINDy (sparse identification of nonlinear dynamics).

Great didactic at #MathOnco25 by @rrockne.bsky.social who starts his presentation with a very Freudian slip by thanking organizers @gliomath.bsky.social and #SINDy (meaning @sandyanderson.bsky.social)

First plenary talk at #MathOnco25 today is Harvard's Galit Lahav about the temporal dynamics of p53 and how it lends itself to #MathModeling

Day 2 of #mathonco25 in St Pete Beach, FL

Great didactic at #MathOnco25 by @dwodarz.bsky.social showing the importance of space...and turnover in #cancerevolution

Our own Tatiana Miti highlighting the importance of data to find out the initial configuration of an ABM describing early stages in metastasis, something which is hard to study with experimental models and clinical data #MathOnco25

A man after my own heart! @dwodarz.bsky.social on the importance of spatial structure in tumour evolution #MathOnco25

At #MathOnco25, @cancerevo.org talks about how to model the role of the tumor microenvironment in cancer initiation, progression, and treatment resistance. He finishes by advertising the Moffitt IMO PhD program www.moffitt.org/education/re...

Now at #MathOnco25, @ceel-damaghilab.bsky.social advocates "3D spheroids as a simplest model of tumor ecosystem". His beautiful data make a strong case.

First didactic of the day at #MathOnco25 is Stony Brook's @ceel-damaghilab.bsky.social about the breast ecosystem. The early breast cancer ecosystem is a tumor incubator

Setting the tone for #MathOnco25, @stroblmar.bsky.social (now based in London) outlines the benefits of theory-experiment integration

Co-organiser @sandyanderson.bsky.social is about to kick off the four-day #MathOnco25 meeting. And you can join us online! moffitt.zoom.us/j/95801446916

Well, #IMO retreat is underway now and here is our very own @sandyanderson.bsky.social describing some of the changes and accomplishments at @mathonco.bsky.social since our last retreat in 2018

Next ups is panel 3 at #NFCR with Elena @fertiglab.bsky.social from @genomescience.bsky.social discussing the role of ‘AI in early detection and prevention’

Paul @mathcancer.bsky.social was rocking the stage at #NFCR as part of the second panel discussion on ‘AI in cancer diagnosis and management’. It’s cool to see the important role of #MathOnco folks in these types of discussions.

Really thrilled to be at the National Press Club today for the NFCR Summit on Cancer Care. My great friend @sandyanderson.bsky.social is on the first panel on AI and cancer care. I'll be on the next panel. :-) 🧪

Always a thrill to see my dear friend @sandyanderson.bsky.social present his groundbreaking work in model-guided adaptive cancer therapy at this year's @jktgfoundation.bsky.social breast cancer symposium. 🧪

Last weeks @mathonco.bsky.social research in progress is by Agata Xella from the #AndersonLab presenting, Modeling CDC7i and PKMYT1i Synergy in Ovarian Cancer @moffittnews.bsky.social

Fab closing presentation by friend and #mathonco agitator @gliomath.bsky.social from @cedarssinaicancer.bsky.social presenting cool new work, Every Patient Deserves Their Own Equation: Towards Digital Twins for Neuro-Oncology.

The penultimate talk is from friend and collaborator Mark Chaplain from St. Andrews University presenting, A Mathematical Modelling Framework for a Virtual Solid Tumour: Foundation for an Oncological Digital Twin.

Next up is Katie Bentley from @crick.ac.uk on Simulating pathological vascular dynamics.

Opening the afternoon session is Hector Gomez from Purdue University presents, Prostate: Small Organ, Big Problems—informing clinical decisions with computational models.

Excited to announce that registration for the 13th @mathonco.bsky.social workshop on Treatment Revolution is now open. Held onsite @moffittnews.bsky.social Nov 2-Nov 7 #MoffittIMO more details: imo13.eventbrite.com. Deluxe travel awards are available on a competitive basis, apply by 10/03!

Closing the morning session is Olivier Gevaert from @stanforduniversity.bsky.social presenting, Multimodal data fusion for precision medicine and digital twins.

Next is friend and fellow Department chair @gibin.bsky.social from @swanseauni.bsky.social presenting, A Multiscale Modelling Framework for Studying Cancer Growth and Treatment Responses.

Next is Simon Walker-Samuel @ucl.ac.uk presenting, Digital twins of the retina as a model for cancer.

Interested in doing a PhD in #MatOnco next year? Our department at @moffittnews.bsky.social is a great place to do research and we offer fully-paid tuition and fees. Apply before the deadline 12/1 at Moffitt.org/CancerPhD

Then our very own Jill Gallaher discusses our ongoing @evoltherapy.bsky.social clinical trial with @genentech.bsky.social on, Adaptive therapy in advanced basal cell carcinoma driven by imaging and predictive mathematical. #AndersonLab @mathonco.bsky.social @moffittnews.bsky.social

Next up was short presentations by Luciana Luque from @cruk-si.bsky.social discussing, From measurement to decision: a tissue-aware digital-twin platform for CAR T cell dosimetry.

Opening day 2 of Mathematical Foundations of Oncological Digital Twins at The NewtonI nstitute is Trachette Jackson from @umich.edu presenting, From PD-L1 to PSA: Virtual Clones and Cohorts in Action Across Cancer Types and Therapeutic Modalities.

Final presentation for today by Richard Gilbertson from Cambridge University and CRUK Cambridge Institute presenting, Context Drift and the Virtual Mouse: new approaches to better cancer treatments.

Next Justicia Kyeremeh from Cambridge University presenting, From Data to Decisions: Building the Digital Twin Framework for Personalised Kidney Cancer Surgery.

Opening the final session for today is Anna Sher from GSK presenting, Oncological Digital Twins in Drug Discovery and Development: A Quantitative Systems Pharmacology Perspective. Sadly most of the slides couldn’t be shared. But Anna’s message was industry is ready to share!

Opening the afternoon session is Jasmine Fisher from @ucl.ac.uk presenting, Precision Oncology through Digital Twins: Mechanisms, Models, and Clinical Applications.